Historical record - last NADAC effective date: 9/21/2022
Product Information
DOXEPIN 50 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.3658 per EA under NDC 69238117101. Its NADAC has been published 264 times since Sep 13, 2017.
FDA first approved this application on Jun 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238117101
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/21/2022
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207482FDA Approved
6/28/2017
TE Code
AB
On Market Since
6/28/2016
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 50 MG CAPSULE has been published 264 times since Sep 13, 2017, and over the history we have for it it has declined 53.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3658 per EA |
|---|---|
| All-time high | $0.8145 (Nov 15, 2017) |
| All-time low | $0.3135 (Jan 19, 2022) |
| Median price | $0.5011 |
| Average price | $0.5393 |
| Largest weekly change | +29.6% (Dec 22, 2021) |
| Weeks tracked | 264 |
| Tracking since | Sep 13, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-17.9%
All
-53.3%
Last surveyed Sep 28, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 58% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXEPIN 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 50 MG CAPSULE, manufactured by Amneal Pharmaceuticals NY LLC, is $0.3658 per EA (NDC 69238117101), effective Sep 28, 2022.
How has the price of DOXEPIN 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOXEPIN 50 MG CAPSULE has declined 53.3%. It has been tracked across 264 weekly CMS publications since Sep 13, 2017.
What are the highest and lowest recorded NADAC prices for DOXEPIN 50 MG CAPSULE?
Since Sep 13, 2017, the NADAC for DOXEPIN 50 MG CAPSULE has ranged from a low of $0.3135 (Jan 19, 2022) to a high of $0.8145 (Nov 15, 2017), with a median of $0.5011 per EA.
Are there cheaper alternatives to DOXEPIN 50 MG CAPSULE?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXEPIN 50 MG CAPSULE, is $0.1535 per EA — about 58% below DOXEPIN 50 MG CAPSULE.
Who manufactures DOXEPIN 50 MG CAPSULE?
DOXEPIN 50 MG CAPSULE (NDC 69238117101) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.